Lantern Pharma Inc (LTRN) — Financial Flexibility Index
Lantern Pharma Inc (LTRN) has a Financial Flexibility Index of -1.13x as of September 2025. Free cash flow of $-4.57 Million (operating CF $-4.57 Million minus capex $560.00) represents -1% of total liabilities ($4.04 Million). Check LTRN strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lantern Pharma Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Lantern Pharma Inc across 7 annual periods. See LTRN working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Lantern Pharma Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Lantern Pharma Inc. For the full company profile including market capitalisation, see market value of Lantern Pharma Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.06x | $-17.80 Million | $-17.81 Million | $4.38 Million | ▲ +22.4% |
| 2023 | -5.23x | $-14.33 Million | $-14.35 Million | $2.74 Million | ▼ -14.9% |
| 2022 | -4.55x | $-12.74 Million | $-12.77 Million | $2.80 Million | ▼ -2.4% |
| 2021 | -4.45x | $-10.58 Million | $-10.59 Million | $2.38 Million | ▲ +47.9% |
| 2020 | -8.53x | $-5.64 Million | $-5.65 Million | $660.84K | ▼ -96.6% |
| 2019 | -4.34x | $-2.12 Million | $-2.13 Million | $489.29K | ▼ -123.3% |
| 2018 | -1.94x | $-1.27 Million | $-1.27 Million | $651.63K | — |